Dupixent and Narrowband UVB for Atopic Dermatitis

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

NCT05369403 ·Status: COMPLETED ·Phase: PHASE3

Topical Psoriasis Study for Patients Receiving Biologic Therapy

NCT02983981 ·Status: COMPLETED ·Phase: PHASE4

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

NCT02412644 ·Status: COMPLETED ·Phase: PHASE4

Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults

NCT05976386 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

NCT06687980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

NCT05203315 ·Status: COMPLETED ·Phase: PHASE3

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

NCT00001797 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

NCT06687967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

NCT00800982 ·Status: COMPLETED ·Phase: NA

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

NCT04202679 ·Status: COMPLETED ·Phase: PHASE3

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

NCT00110981 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

NCT03020199 ·Status: COMPLETED ·Phase: PHASE4

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

NCT04999839 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject

NCT02303509 ·Status: COMPLETED ·Phase: PHASE1

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

NCT06226610 ·Status: RECRUITING ·Phase: PHASE2

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

NCT05014438 ·Status: COMPLETED ·Phase: PHASE2

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

NCT03298581 ·Status: WITHDRAWN ·Phase: PHASE2

Bexarotene With Narrow-Band UVB for Psoriasis

NCT00151008 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3041658 in Participants With Skin Diseases

NCT02896868 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

NCT07330934 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

NCT00096980 ·Status: COMPLETED ·Phase: PHASE4

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

NCT02525094 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

NCT02413229 ·Status: COMPLETED ·Phase: PHASE2

Upadacitinib for Prurigo Nodularis

NCT06773403 ·Status: TERMINATED ·Phase: PHASE4